PDF herunterladen
Synlett 2018; 29(09): 1207-1210
DOI: 10.1055/s-0037-1609338
letter
© Georg Thieme Verlag Stuttgart · New York

One-Pot Highly Regioselective Synthesis of Indole-Fused Pyridazino[4,5-b][1,4]benzoxazepin-4(3H)-ones by a Smiles Rearrangement

Xiaolei Jiang
School of Chemistry and Chemical Engineering, Linyi University, Linyi, Shandong 276005, P. R. of China   eMail: hufangdong@lyu.edu.cn
,
Fangdong Hu*
School of Chemistry and Chemical Engineering, Linyi University, Linyi, Shandong 276005, P. R. of China   eMail: hufangdong@lyu.edu.cn
› InstitutsangabenWe are grateful for financial support from Shandong Province Higher Educational Science and Technology Program (Grant No. J17KA099), Shandong Provincial Natural Science Foundation for Doctors Scholar (Grant No. ZR2017BB016), and the Natural Science Foundation of Linyi University (Grant No. LYDX2016BS092).
Weitere Informationen

Publikationsverlauf

Received: 18. Januar 2018

Accepted after revision: 13. Februar 2018

Publikationsdatum:
05. März 2018 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik


Abstract

A simple and convenient synthesis of indole-fused pyridazino[4,5-b][1,4]benzoxazepin-4(3H)-ones is described. A range of 2-(1H-indol-2-yl)phenols and 4,5-dichloropyridazin-3-ones are compatible with this reaction. A Smiles rearrangement is proposed as a key step in the highly regioselective construction of the products. The easy availability of the starting materials makes this an appealing method in ­organic synthesis.

Key words

indoles - indolopyridazinobenzoxazepinones - regioselectivity - polycyclic heterocycles - Smiles rearrangement

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/s-0037-1609338.
  • Supporting Information
 

  • References and Notes

  • 1 Hallinan EA. Stapelfeld A. Savage MA. Reichman M. Bioorg. Med. Chem. Lett. 1994; 4: 509
    CrossrefSuche in Google Scholar
  • 2 Ouyang X. Tamayo N. Kiselyov AS. Tetrahedron 1999; 55: 2827
    CrossrefSuche in Google Scholar
  • 3 Dols PP. M. A. Folmer BJ. B. Hamersma H. Kuil CW. Lucas H. Ollero L. Rewinkel JB. M. Hermkens PH. H. Bioorg. Med. Chem. Lett. 2008; 18: 1461
    CrossrefSuche in Google Scholar
  • 4 Dorn A. Schattel V. Laufer S. Bioorg. Med. Chem. Lett. 2010; 20: 3074
    CrossrefSuche in Google Scholar
  • 5 Gijsen HJ. M. Berthelot D. Zaja M. Brône B. Geuens I. Mercken M. J. Med. Chem. 2010; 53: 7011
    CrossrefPubMedSuche in Google Scholar
  • 6 Binaschi M. Boldetti A. Gianni M. Maggi CA. Gensini M. Bigioni M. Parlani M. Giolitti A. Fratelli M. Valli C. Terao M. Garattini E. ACS Med. Chem. Lett. 2010; 1: 411
    CrossrefPubMedSuche in Google Scholar
  • 7 Lu S.-M. Alper H. J. Am. Chem. Soc. 2005; 127: 14776
    CrossrefPubMedSuche in Google Scholar
  • 8 Liu Y. Chu C. Huang A. Zhan C. Ma Y. Ma C. ACS Comb. Sci. 2011; 13: 547
    CrossrefPubMedSuche in Google Scholar
  • 9 Liu Y. Ma Y. Zhang C. Huang A. Ma C. Synlett 2012; 23: 255
    Thieme ConnectSuche in Google Scholar
  • 10 Sapegin AV. Kalinin SA. Smirnov AV. Dorogov MV. Krasavin M. Synthesis 2012; 44: 2401
    Thieme ConnectSuche in Google Scholar
  • 11 Kochanowska-Karamyan AJ. Hamann MT. Chem. Rev. 2010; 110: 4489
    CrossrefSuche in Google Scholar
  • 12 Li S.-M. Nat. Prod. Rep. 2010; 27: 57
    CrossrefSuche in Google Scholar
  • 13 Cho S.-D. Park Y.-D. Kim J.-J. Lee S.-G. Ma C. Song S.-Y. Joo W.-H. Falck JR. Shiro M. Shin D.-S. Yoon Y.-J. J. Org. Chem. 2003; 68: 7918
    CrossrefPubMedSuche in Google Scholar
  • 14 Cho S.-D. Song S.-Y. Park Y.-D. Kim J.-J. Joo W.-H. Shiro M. Falck JR. Shin D.-S. Yoon Y.-J. Tetrahedron Lett. 2003; 44: 8995
    CrossrefSuche in Google Scholar
  • 15 Cho S.-D. Park Y.-D. Kim J.-J. Joo W.-H. Shiro M. Esser L. Falck JR. Ahn C. Shin D.-S. Yoon Y.-J. Tetrahedron 2004; 60: 3763
    CrossrefSuche in Google Scholar
  • 16 Zuo H. Li Z.-B. Ren F.-K. Falck JR. Meng L. Ahn C. Shin D.-S. Tetrahedron 2008; 64: 9669
    CrossrefSuche in Google Scholar
  • 17 Zuo H. Meng L. Ghate M. Hwang K.-H. Cho YK. Chandrasekhar S. Reddy CR. Shin D.-S. Tetrahedron Lett. 2008; 49: 3827
    CrossrefSuche in Google Scholar
  • 18 Zhao Y. Wu Y. Jia J. Zhang D. Ma C. J. Org. Chem. 2012; 77: 8501
    CrossrefPubMedSuche in Google Scholar
  • 19 Zhao Y. Dai Q. Chen Z. Zhang Q. Bai Y. Ma C. ACS Comb. Sci. 2013; 15: 130
    CrossrefPubMedSuche in Google Scholar
  • 20 Yang B. Tan X. Guo R. Chen S. Zhang Z. Chu X. Xie C. Zhang D. Ma C. J. Org. Chem. 2014; 79: 8040
    CrossrefSuche in Google Scholar
  • 21 Niu X. Yang B. Li Y. Fang S. Huang Z. Xie C. Ma C. Org. Biomol. Chem. 2013; 11: 4102
    CrossrefPubMedSuche in Google Scholar
  • 22 Kitching MO. Hurst TE. Snieckus V. Angew. Chem. Int. Ed. 2012; 51: 2925
    CrossrefPubMedSuche in Google Scholar
  • 23 Zhou Y. Zhu J. Li B. Zhang Y. Feng J. Hall A. Shi J. Zhu W. Org. Lett. 2016; 18: 380
    CrossrefPubMedSuche in Google Scholar
  • 24 Zhan C. Jia J. Yang B. Huang A. Liu Y. Ma C. RSC Adv. 2012; 2: 7506
    CrossrefSuche in Google Scholar
  • 25 Sang P. Yu M. Tu H. Zou J. Zhang Y. Chem. Commun. 2013; 49: 701
    CrossrefPubMedSuche in Google Scholar
  • 26 CCDC 1581528 contains the supplementary crystallographic data for compound 3n. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.
  • 27 Indolo[1,2-d]pyridazino[4,5-b][1,4]benzoxazepin-9(8H)-ones 3a–r; General Procedure The appropriate 2-(1H-indol-2-yl)phenol 1 (0.30 mmol), 2-tetra­hydropyranylpyridazin-3-one 2 (0.30 mmol), and K2CO3 (2.5 equiv.) were successively added to a 10 mL Schlenk tube. DMF (2 mL) was then added from a dropper and the resulting solution was stirred at 80 °C for 3 h. The mixture was cooled to r.t. then extracted with EtOAc (×3). The combined organic phase was washed with brine, dried (Na2SO4), and filtered. The solvent was then removed in vacuoto give a crude mixture that was purified by column chromatography (silica gel). 8-(Tetrahydro-2H-pyran-2-yl)indolo[1,2-d]pyridazino[4,5-b][1,4]benzoxazepin-9(8H)-one (3a) Light-yellow solid; yield: 104 mg (90%); mp 122–124 °C. 1H NMR (500 MHz, CDCl3): δ = 8.43 (s, 1 H), 7.72–7.70 (m, 2 H), 7.66 (d, J = 8.2 Hz, 1 H), 7.54–7.52 (m, 1 H), 7.40–7.27 (m, 4 H), 6.98 (s, 1 H), 6.15–6.13 (m, 1 H), 4.17–4.14 (m, 1 H), 3.81–3.76 (m, 1 H), 2.23–2.15 (m, 1 H), 2.07–2.04 (m, 1 H), 1.80–1.71 (m, 3 H), 1.60–1.58 (m, 1 H). 13C NMR (125 MHz, CDCl3): δ = 157.55, 157.02, 144.65, 136.58, 135.94, 133.09, 131.39, 130.48, 129.45, 129.39, 126.36, 123.99, 123.54, 122.82, 122.15, 121.69, 111.56, 105.97, 83.32, 68.98, 28.99, 24.89, 22.83. HRMS (ESI): m/z [M + H]+ calcd for C23H20N3O3: 386.1499; found: 386.1491.